Entourage Health Corp. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was CAD 13.44 million compared to CAD 14.98 million a year ago. Revenue was CAD 10.08 million compared to CAD 10.79 million a year ago. Net loss was CAD 17.43 million compared to CAD 17.47 million a year ago. Basic loss per share from continuing operations was CAD 0.06 compared to CAD 0.07 a year ago. Diluted loss per share from continuing operations was CAD 0.06 compared to CAD 0.07 a year ago.
For the nine months, sales was CAD 42.39 million compared to CAD 41.69 million a year ago. Revenue was CAD 32.19 million compared to CAD 31.67 million a year ago. Net loss was CAD 35.22 million compared to CAD 34.43 million a year ago. Basic loss per share from continuing operations was CAD 0.12 compared to CAD 0.15 a year ago. Diluted loss per share from continuing operations was CAD 0.12 compared to CAD 0.15 a year ago.